North America Neurostimulation Devices Market

North America Neurostimulation Devices Market size was valued at USD 3.1 billion in 2025 and is forecast to grow from USD 3.4 billion in 2026 to reach USD 5.3 billion by 2031, at a CAGR of 11.2%.

Description

The North America Neurostimulation Devices Market size was valued at USD 3.1 billion in 2025 and is forecast to grow from USD 3.4 billion in 2026 to reach USD 5.3 billion by 2031, at a CAGR of 11.2%. Neurostimulation devices deliver targeted electrical impulses to the brain, spinal cord, or peripheral nerves to modulate neural activity, offering minimally invasive alternatives to long-term pharmacological therapy for chronic pain, movement disorders, epilepsy, and psychiatric conditions. The market sits at the intersection of neurotechnology, implantable medical devices, and precision healthcare, making it one of the most closely watched enabling technologies across the regional neurological-care value chain.

Demand for neurostimulation platforms remains anchored by the rising prevalence of chronic pain, Parkinson's disease, epilepsy, and treatment-resistant depression, alongside expanding reimbursement coverage and clinician preference for device-based interventions that reduce long-term pharmacological dependence across the United States, Canada, and Mexico. Beyond pain management, neurostimulation continues to enable applications in movement-disorder therapy, urinary and fecal incontinence treatment, and emerging psychiatric-disorder indications that require precise, patient-specific neural modulation. Rising healthcare expenditure, expanding outpatient and ambulatory-surgery-center procedure volumes, and continued innovation in closed-loop and adaptive stimulation technology are sustaining consumption even as the region transitions toward more personalized, responsive neurostimulation therapies.

Table of Contents

  • Product Overview

    1. Market Definition

    2. Scope of the Market

      1. Markets Covered

      2. Years Considered for Study

      3. Key Market Segmentations

  • Research Methodology

    1. Objective of the Study

    2. Baseline Methodology

    3. Key Industry Partners

    4. Major Association and Secondary Sources

    5. Forecasting Methodology

    6. Data Triangulation & Validation

    7. Assumptions and Limitations

  • Executive Summary

    1. Overview of the Market

    2. Overview of Key Market Segmentations

    3. Overview of Key Market Players

    4. Overview of Key Regions/Countries

    5. Overview of Market Drivers, Challenges, Trends

  • Voice of Customer

  • North America Neurostimulation Devices Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product (Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Others)

      2. By Application (Pain Management, Parkinson's Disease, Epilepsy, Urinary & Fecal Incontinence, Others)

      3. By End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, Others)

      4. By Country

      5. By Company (2025)

    3. Product Map

  • United States Neurostimulation Devices Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product

      2. By Application

      3. By End User

  • Canada Neurostimulation Devices Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product

      2. By Application

      3. By End User

  • Mexico Neurostimulation Devices Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product

      2. By Application

      3. By End User

  • Market Dynamics

    1. Drivers

    2. Challenges

  • Market Trends & Developments

    1. Merger & Acquisition (If Any)

    2. Product Launches (If Any)

    3. Recent Developments

  • North America Neurostimulation Devices Market: SWOT Analysis

  • Porter's Five Forces Analysis

    1. Competition in the Industry

    2. Potential of New Entrants

    3. Power of Suppliers

    4. Power of Customers

    5. Threat of Substitute Products

  • Competitive Landscape

    1. Medtronic plc

      1. Business Overview

      2. Products & Services

      3. Recent Developments

      4. Key Personnel

      5. SWOT Analysis

    2. Boston Scientific Corporation

    3. Abbott Laboratories

    4. Nevro Corp.

    5. LivaNova PLC

    6. NeuroPace, Inc.

    7. Axonics, Inc.

    8. electroCore, Inc.

    9. Synapse Biomedical Inc.

    10. Integer Holdings Corporation

  • Strategic Recommendations

  • About Us & Disclaimer

    • Methodology